NDT Advance Access originally published online on December 4, 2008
Nephrology Dialysis Transplantation 2009 24(2):661-666; doi:10.1093/ndt/gfn656
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
BK virus RNA can be detected in archival renal transplant biopsies using the reverse trancription polymerase chain reaction
1 Department of Medicine, St Vincent's Hospital, University of Melbourne, Clinical Sciences Building, Cnr Princes and Regent Streets, Fitzroy Victoria 3065 2 Department of Nephrology, St. Vincent's Hospital, PO Box 2900, Fitzroy Victoria 3065 3 Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton Victoria 3168 4 Department of Anatomical Pathology, St. Vincent's Hospital, PO Box 2900, Fitzroy, Victoria 3065 5 Department of Anatomical Pathology, Monash Medical Centre. 246 Clayton Road, Clayton Victoria 3168, Australia
Correspondence and offprint requests to: Kathryn J. Wiggins, Department of Medicine, St. Vincent's Hospital, University of Melbourne, Level 4, Clinical Sciences Building, Cnr Princes and Regent Streets, Fitzroy VIC 3065, Australia. Tel: +61-3-9288-2211; Fax: +61-3-9288-3151; E-mail: kwiggins@medstv.unimelb.edu.au
Keywords: archival renal biopsy; BK virus; PCR; renal transplant; RNA
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
BK virus (BKV) nephropathy (BKVN), also known as polyoma virus nephropathy (PVAN), is a significant cause of allograft dysfunction and loss in renal transplant recipients. Early reports of this condition suggested that the rate of graft failure due to BKVN was 50–80% [1–3]. Since the publication of these reports, increased awareness and progressively widespread availability of PCR assays to detect viral DNA in urine and blood have led to early recognition and diagnosis of this condition [4]. However, a contemporary case series of patients who received transplants in a centre where PCR was used as a screening tool still reported major decline in graft function in 24% of affected individuals, and graft loss in 15% [5]. Initial treatment for BKVN involves reduction of immunosuppression. Although generally well tolerated, this is associated with a risk of subsequent acute rejection (AR) [6,7]. These findings
| Materials and methods |
|---|
Subjects
Renal biopsies
RNA extraction
Polymerase chain reaction (PCR)
Histological analysis
Quantification of tissue fibrosis
Statistical analysis
| Results |
|---|
Patient characteristics
BKVN in renal biopsies
BKV RNA detection
Relationship between relative viral load and clinical course
Comparison of RT-PCR and histology
| Discussion |
|---|
| Supplementary data |
|---|